spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

BioTrinity 2018

23-25 April 2018
Novotel London West in Hammersmith

BioTrinity 2018 is taking place from 23-25 April at the Novotel London West in Hammersmith. Now in its 12th year, BioTrinity remains the leading life sciences biopartnering and investment conference in Europe, and is a must attend event for R&D companies, TTO’s and academia who are looking to meet, collaborate, partner and seek funding from Big Pharma, Investors and Associated Industry companies.

Each year we seek to improve and evolve the format of the conference in-line with industry trends and to meet the changing demands of our delegates, with key highlights including:

·        Over 2,000 private partnering meetings supported by the partneringONE™ booking system

·        Innovative and insightful programme of keynote presentations, panel discussions and round table debates exploring the latest hot topics in the industry

·        BioLaunchPad™ - a single track series of Company Showcase presentations, all in one room, with an audience capacity of up to 200

·        An improved environment in the partnering area including additional lounge areas and branded coffee stands

·        Refined programme of networking events to further support collaboration and partnership opportunities between delegates.

Our theme for BioTrinity 2018 is ‘Next Generation Healthcare’ which we will explore via a range of insightful keynote and panel discussions including ‘AI and Drug Discovery’, ‘An insight into Nanotechnology’, ‘Next Generation Chemistry’ and ‘Fintech and the Future of the Investment Industry’ – more updates on speakers and topics will follow soon.

A general delegate ticket includes access to the whole conference, including the use of the partneringONE™ meeting scheduler, access to keynote and panel discussions, BioLaunchPad™ company showcase presentations, all social networking events and full catering throughout the conference.
Special rates are available to OBN Members, who can save up to £300 per delegate. Please contact our Membership Manager (Nicola Westgate – nicola.westgate@obn.org.uk) to find out if you are eligible for a member rate or to enquire about becoming an OBN Member. Please note that ticket prices increase in the run-up to the event – the earlier you book, the more money you save!

Please visit www.biotrinity.comfor up to date information.

Organiser contact details:

OBN Events Team
events@obn.org.uk

 
Print this page
Send to a friend
   
spacer
Industry Events

Clinical Innovation Partnerships

11-12 September 2019, Hotel Palace, Berlin

Clinical Innovation Partnerships is the only event for senior clinical operations and procurement professionals driving innovation in their clinical trials. It is where the pharma, CRO and vendor clinical trials ecosystem meet to drive innovation in digitalisation, tech and partnering to improve patient experience and reduce trial cost and time.
More info >>


White Papers

Syringe siliconization

Gerresheimer AG

Ready-to-fill, i.e. sterile, prefillable glass syringes, are washed, siliconized, sterilized and packaged by the primary packaging manufacturer. They can then be filled by the pharmaceutical companies without any further processing. These days the majority of prefillable syringes are made of glass and the trend looks set to continue. The siliconization of the syringe barrel is an extremely important aspect of the production of sterile, prefillable glass syringes because the functional interaction of the glass barrel siliconization and the plunger stopper siliconization is crucial to the efficiency of the entire system. Both inadequate and excessive siliconization can cause problems in this connection. The use of modern technology can achieve an extremely uniform distribution of silicone oil in glass syringes with reduced quantities of silicone oil. Another option for minimizing the amount of free silicone oil in a syringe is the thermal fixation of the silicone oil on the glass surface in a process called baked-on siliconization. Plastic-based silicone oil-free or low-silicone oil prefillable syringe systems are a relatively new development. Silicone oil-free lubricant coatings for syringes are also currently in the development phase.
More info >>


News and Press Releases

CPhI MEA expert:growing domestic manufacturing is creating new opportunities for international Pharma in the Middle East

Abu Dhabi, 5th August 2019: CPhI Middle East expert Emad Shabbir, Director at EMAD Trade House, states favorable conditions and legislative regulations in Saudi Arabia are resulting in a boom of manufacturers and CMOs partnerships with international pharma companies. With the strategic cooperation between regional generic companies and multinational pharma companies, driving increased local production.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement